Evidence map›Paper›PMID 39066651›Full record

ArticleIntegrative cancer therapies

Assessing Fidelity in Yoga Interventions for Chemotherapy-Induced Peripheral Neuropathy: Decision-Making to Enhance Protocol Quality Adherence.

Kirin Saint, Tina Paul, Clare Patterson, Mingxiao Yang, Ting Bao, Mary Lou Galantino

Abstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kirin SaintUniversity of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-0803-7743
Tina PaulMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Clare PattersonMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Mingxiao YangDana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Ting BaoDana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Mary Lou GalantinoMemorial Sloan Kettering Cancer Center, New York, NY, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)TrialR37CA248563 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Ting Bao · 2021 to 2026
$3.9M
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) TrialR01CA251470 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BAO, TING · 2021 to 2025
$3.6M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA251470NCI NIH HHS R37 CA248563
6 · The paper itself

Abstract

backgroundYoga interventions need fidelity monitoring to standardize the trial process and ensure adherence. We examined fidelity measures of current yoga trials and developed a fidelity assurance process in a phase III randomized clinical trial addressing chemotherapy-induced peripheral neuropathy among cancer survivors.

methodsWe qualitatively analyzed the fidelity monitoring components in published clinical trials on yoga therapy for chemotherapy-induced peripheral neuropathy through a literature search in PubMed from inception to February 2023. Leveraging fidelity measures for community-based, complex interventions and yoga therapy reporting guidelines, we developed an instructor/participant-oriented fidelity checking approach in an ongoing phase III trial evaluating yoga for improving chemotherapy-induced peripheral neuropathy in cancer survivors. Two researchers independently assessed 4 of 8 video recordings of yoga instructor-led training sessions (50%) and participant-kept home practice logs using a developed fidelity checklist.

resultsNone of the 4 eligible yoga trials specifically have intervention fidelity measures. We prospectively incorporated yoga instructor training, virtual delivery, and participant engagement strategies in the phase III trial protocol following guidelines. All trial yoga instructors were trained under study protocol to ensure compliance and participant engagement. There was high intervention fidelity in all instructor-led virtual sessions: an average of 100% adherence to class structure and three-thirds on specific skills. Assessment of participant adherence to the established home yoga protocol was 63%.

conclusionYoga trials for chemotherapy-induced peripheral neuropathy need adequate fidelity measures. Our study provides a feasible fidelity-monitoring approach to ensure trial intervention delivery and protocol adherence by instructors and participants in oncological settings.

Indexed as

Antineoplastic AgentsPeripheral Nervous System DiseasesYogaCancer SurvivorsDecision MakingHumansNeoplasmsAntineoplastic Agentscancer survivorshipchemotherapy-induced peripheral neuropathyintervention fidelityprotocol adherencesymptom managementyoga therapy

Identifiers

PMID39066651
PMCPMC11283657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.